TRUST ANALGESIC CALMATIVE paracetamol 500mg + codeine phosphate hemihydrate 10mg + doxylamine succinate 5.1mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

trust analgesic calmative paracetamol 500mg + codeine phosphate hemihydrate 10mg + doxylamine succinate 5.1mg tablets blister pack

pharmacor pty ltd - paracetamol, quantity: 500 mg; codeine phosphate hemihydrate, quantity: 10 mg; doxylamine succinate, quantity: 5.1 mg - tablet, uncoated - excipient ingredients: crospovidone; lactose monohydrate; stearic acid; magnesium stearate; maize starch; ethanol; povidone; microcrystalline cellulose - for the temporary relief of acute moderate pain and fever.

Dolased Forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dolased forte (paracetamol 450 mg, codeine phosphate hemihydrate 30 mg, doxylamine succinate 5 mg) tablets blister pack

aspen pharmacare australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg; paracetamol, quantity: 450 mg - tablet, uncoated - excipient ingredients: stearic acid; crospovidone; glyceryl monostearate; magnesium stearate; lactose monohydrate; povidone; pregelatinised maize starch - dolased forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Syndol Film-coated Tablets Paracetamol 450 mg Codeine Phosphate Hemihydrate 10 mg Doxylamine succinate 5 mg Caffeine 30 mg Ireland - English - HPRA (Health Products Regulatory Authority)

syndol film-coated tablets paracetamol 450 mg codeine phosphate hemihydrate 10 mg doxylamine succinate 5 mg caffeine 30 mg

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate; doxylamine succinate; caffeine - film-coated tablet - 450mg/10mg/5mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

MEVADOL FORTE paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mevadol forte paracetamol 450 mg/ codeine phosphate hemihydrate 30 mg/ doxylamine succinate 5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

CIPLA PAIN RELIEF PARACETAMOL + CODEINE with CALMATIVE tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

cipla pain relief paracetamol + codeine with calmative tablet blister pack

cipla australia pty ltd - doxylamine succinate, quantity: 5.1 mg; codeine phosphate hemihydrate, quantity: 10 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; purified talc; magnesium stearate; pregelatinised maize starch; sodium lauryl sulfate; colloidal anhydrous silica; hyprolose; stearic acid - for the temporary relief of acute moderate pain

MERSYNDOL FORTE paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

mersyndol forte paracetamol 450 mg / codeine phosphate hemihydrate 30 mg / doxylamine succinate 5 mg tablet blister pack

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 30 mg; paracetamol, quantity: 450 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: sodium starch glycollate; magnesium stearate; purified talc; stearic acid; povidone; pregelatinised maize starch; crospovidone - indications as at 9 june 2020: mersyndol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

MAXYDOL tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

maxydol tablet blister pack

cipla australia pty ltd - codeine phosphate hemihydrate,doxylamine succinate,paracetamol -